3 Healthcare Startups that are Bringing Hope to the Fight Against Incurable Diseases
Some diagnoses signify an uncertain future fraught with unenviable personal challenges and irreversible changes in the patient’s life. During these difficult times, modern medicine is rarely of any comfort, as the available host of treatments fails to prevent or sometimes even delay the onset of the disease.
Fortunately, some healthcare startups are forging new paths on the road to defeating previously unbeatable pathologies.
Alector
There is new hope on the horizon for those suffering from Alzheimer’s thanks to healthcare startup, Alector’s, leveraging of cutting-edge advances in antibody technology and neuroimmunology.
Using its proprietary, antibody technology, the company creates drugs that work by attacking disease-affecting targets for conditions such as Alzheimer’s and other strains of dementia.
BenevolentAI
Artificial Intelligence is being used by researchers at this healthcare startup to produce real results. BenevolentAI’s intelligent software unravels what occurs at the molecular level as symptoms for different diseases unfold in order to discover new ways to pair patients with better drug treatments. In this way, BenevolentAI is able to better connect patients with more robust treatments and help create cures for previously-incurable conditions.
Some of the diseases that BenevolentAI has in its crosshairs include Parkinson’s, motor neuron disorders, and a variety of cancers.
Paige
Despite its name, Paige will likely end up being a White Knight to the many suffering from cancer. Employing sophisticated deep learning software, generative models, recurrent neural networks, and other powerful pillars from the world of Artificial Intelligence, Paige leverages information from thousands of slides obtained from clinicians to devise new ways of combating cancer.
The Bottom Line
Healthcare startups are using high-powered, AI-based solutions to redefine the approach modern medicine takes to complicated, poorly-understood, medical polemics. Cures for these conditions are awaiting discovery, and the algorithms developed by these inventive healthcare startups are helping the medical establishment plot the course to a new era in which these diseases become stumbling stones instead of death sentences.
More importantly, as these healthcare startups demonstrate the benefits of using artificial intelligence to rethink the way we perceive treatment-resistant conditions, other members of the pharmaceutical industry will increase their investment in AI-powered development methods, leading to an increase in momentum for AI-based discoveries.
